- Report
- July 2026
- 150 Pages
Global
From €3379EUR$3,750USD£2,899GBP
- Report
- August 2026
- 120 Pages
Global
From €4280EUR$4,750USD£3,672GBP
- Report
- August 2026
- 110 Pages
Global
From €4280EUR$4,750USD£3,672GBP
- Report
- August 2026
- 182 Pages
Global
From €4280EUR$4,750USD£3,672GBP
- Report
- July 2026
- 114 Pages
Global
From €4280EUR$4,750USD£3,672GBP
- Report
- July 2026
- 180 Pages
Global
From €4280EUR$4,750USD£3,672GBP
- Report
- May 2026
- 147 Pages
Global
From €3559EUR$3,950USD£3,054GBP
- Report
- July 2026
- 160 Pages
Global
From €2992EUR$3,320USD£2,567GBP
€3739EUR$4,150USD£3,208GBP
- Report
- April 2026
- 160 Pages
Global
From €2992EUR$3,320USD£2,567GBP
€3739EUR$4,150USD£3,208GBP
- Report
- October 2025
- 160 Pages
Global
From €2847EUR$3,160USD£2,443GBP
€3559EUR$3,950USD£3,054GBP
- Report
- June 2026
- 140 Pages
Global
From €4370EUR$4,850USD£3,749GBP
- Report
- February 2026
- 96 Pages
Global
From €3500EUR$4,161USD£3,108GBP
- Report
- October 2025
- 150 Pages
Global
From €4370EUR$4,850USD£3,749GBP
- Report
- March 2026
- 187 Pages
Global
From €4370EUR$4,850USD£3,749GBP
- Report
- February 2026
Global
From €5001EUR$5,550USD£4,290GBP
- Report
- August 2026
- 200 Pages
Europe
From €2244EUR$2,490USD£1,925GBP
- Report
- September 2024
- 351 Pages
Global
From €3782EUR$4,197USD£3,244GBP
- Report
- July 2020
- 269 Pages
Global
From €3151EUR$3,497USD£2,703GBP
- Report
- March 2022
- 405 Pages
Global
From €4324EUR$4,799USD£3,710GBP
- Report
- February 2025
- 190 Pages
Global
From €4324EUR$4,799USD£3,710GBP

The Exosome market is a subset of the biotechnology industry that focuses on the development of exosome-based therapeutics. Exosomes are small vesicles that are released by cells and contain proteins, lipids, and nucleic acids. They are involved in a variety of biological processes, including cell-to-cell communication, and have been shown to have potential therapeutic applications. Exosome-based therapeutics are being developed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular diseases.
Exosome-based therapeutics are still in the early stages of development, but the potential of these treatments has attracted the attention of many biotechnology companies. Some of the companies in the Exosome market include Exosome Diagnostics, Exosome Sciences, Exosome Technologies, Exosome Therapeutics, and Exosome Sciences. Show Less Read more